High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.
about
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
High-Dose Sirolimus and Immune ...... Graft-versus-Tumor Responses.
@ast
High-Dose Sirolimus and Immune ...... Graft-versus-Tumor Responses.
@en
type
label
High-Dose Sirolimus and Immune ...... Graft-versus-Tumor Responses.
@ast
High-Dose Sirolimus and Immune ...... Graft-versus-Tumor Responses.
@en
prefLabel
High-Dose Sirolimus and Immune ...... Graft-versus-Tumor Responses.
@ast
High-Dose Sirolimus and Immune ...... Graft-versus-Tumor Responses.
@en
P2093
P2860
P1476
High-Dose Sirolimus and Immune ...... Graft-versus-Tumor Responses.
@en
P2093
Antonio Tito Fojo
Ashley Carpenter
Bazetta Blacklock Schuver
Brenna Hansen
Bruce L Levine
Carl H June
Claude Sportes
Daniel H Fowler
David C Halverson
David Stroncek
P2860
P304
P356
10.1158/1078-0432.CCR-15-0340
P407
P50
P577
2015-06-12T00:00:00Z